Food and Drug Administration

Transmissibe Spongiform Encephalopathies Advisory Committee

February 13, 2004

Briefing Information

Current Safeguards for Blood Products: Approach to Products Containing or Exposed to Bovine Materials (HTM) (PDF) (Word)

Minimizing Risks of TSE Agents in Human Tissues (HTM) (PDF) (Word)

The Use of Bovine-Derived Products in the Manufacture of Vaccines and Allergenic Products (HTM) (PDF) (Word)

Current CDER Approaches to Minimizing the Risk of TSE Agents in Drugs (HTM) (PDF) (Word)

CDER Current Recommendations on Measures to Minimize Risk of TSE Agents in Medical Devices (HTM) (PDF) (Word)

Memorandum Regarding TSE/BSE Letter to Manufacturers of FDA-Regulated Medical Devices Containing Animal Tissue Products or Components (PDF)

Impact on FDA-Regulated Foods, Including Dietary Supplements, and Cosmetics (HTM) (PDF) (Word)